Antiretrovirals as antimalarial agents

Tina S Skinner-Adams1, James S McCarthy, Donald L Gardiner

  • 1Malaria Biology Laboratory, Australian Centre for International and Tropical Health and Nutrition, Queensland Institute of Medical Research and School of Population Health, University of Queensland, St. Lucia, Queensland, Australia.

Insights

Certain HIV protease inhibitors, including saquinavir, ritonavir, and indinavir, directly inhibit the growth of malaria parasites (Plasmodium falciparum) in laboratory settings. This discovery is crucial for regions with high rates of HIV and malaria coinfection.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Tropical Medicine

Background:

  • Antiretroviral protease inhibitors are used to treat HIV infection.
  • Emerging evidence suggests these drugs may influence malaria outcomes.
  • Understanding drug interactions is critical in coinfected populations.

Purpose of the Study:

  • To investigate the antimalarial activity of commonly used antiretroviral agents.
  • To determine if specific HIV protease inhibitors directly inhibit Plasmodium falciparum growth.
  • To assess the relevance of these findings in clinical contexts.

Main Methods:

  • In vitro testing of six antiretroviral agents against Plasmodium falciparum.
  • Evaluation of drug effects at clinically relevant concentrations.
  • Review of existing literature on protease inhibitor effects on parasite cytoadherence and phagocytosis.

Main Results:

  • Saquinavir, ritonavir, and indinavir demonstrated direct inhibition of Plasmodium falciparum growth in vitro.
  • These effects were observed at concentrations achievable in patients.
  • Previous findings on cytoadherence and phagocytosis were corroborated.

Conclusions:

  • Specific human immunodeficiency virus (HIV)-1 protease inhibitors possess direct antimalarial activity.
  • These findings have significant implications for managing malaria and HIV coinfection in sub-Saharan Africa.
  • Further research into these drug interactions is warranted for therapeutic strategies.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...